Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-52.00 Mil
% of Total Estimate Gain
-78.17%

Syncona Portfolio Ltd's Achilles Therapeutics PLC Holding Summary

As of 2025-03-31, Syncona Portfolio Ltd held - shares of Achilles Therapeutics PLC(ACHL), totaling N/A. This investment constitutes 0% of their stock portfolio, and Syncona Portfolio Ltd now holds 0% of the outstanding Achilles Therapeutics PLC(ACHL) stock.

The initial trade took place in 2021Q4. In addition, there have been 1 sales at an average price of $1.31 for 11.09 Mil shares. Based on historical transaction data and ACHL's current price of $1.48, Syncona Portfolio Ltd's estimated gain on his ACHL holdings is $-52.00 Mil, reflecting a -78.17% gain to date.

Syncona Portfolio Ltd ACHL ($1.48) Holding Chart

Syncona Portfolio Ltd ACHL ($1.48) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1